Biochemical and biophysical characteristics of lipoplexes pertinent to solid tumour gene therapy

Aberle, 1998, A novel tetraester construct that reduces cationic lipid-associated cytotoxicity. Implications for the onset of cytotoxicity, Biochemistry, 37, 6533, 10.1021/bi9801154 Adams, 1977, The cell biology of macrophage activation, Ann. Rev. Immunol., 2, 283, 10.1146/annurev.iy.02.040184.001435 Alton, 1998, Towards gene therapy for cystic fibrosis: a clinical progress report, Gene Ther., 5, 291, 10.1038/sj.gt.3300655 Anwer, 2000, Targeted gene delivery: a two-pronged approach, Crit. Rev. Ther. Drug Carrier Syst., 17, 377, 10.1615/CritRevTherDrugCarrierSyst.v17.i4.30 Anwer, 2000, Cationic lipid-based delivery system for systemic cancer gene therapy, Cancer Gene Ther., 7, 1156, 10.1038/sj.cgt.7700218 Armeanu, 2000, Optimization of nonviral gene transfer of vascular smooth mucle cells in vitro and in vivo, Mol. Ther., 1, 366, 10.1006/mthe.2000.0053 Balasubramaniam, 1996, Structural and functional analysis of cationic transfection lipids: the hydrophobic domain, Gene Ther., 3, 163 Barron, 1999, Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration, Hum. Gene Ther., 10, 1683, 10.1089/10430349950017680 Barron, 1999, Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes, Gene Ther., 6, 1179, 10.1038/sj.gt.3300929 Bei, 1998, The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice, J. Immunother., 21, 159, 10.1097/00002371-199805000-00001 Bennett, 1997, Cationic lipid-mediated gene delivery to murine lung: correlation of lipid hydration with in vivo transfection activity, J. Med. Chem., 40, 4069, 10.1021/jm970155q Bergan, 2000, Gene transfer in vitro and in vivo by cationic lipids is not significantly affected by levels of supercoiling of a reporter plasmid, Pharm. Res., 17, 967, 10.1023/A:1007531405796 Bielinska, 1996, Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers, Nucl. Acids Res., 24, 2176, 10.1093/nar/24.11.2176 Blezinger, 1999, Intratracheal administration of interleukin 12 plasmid–cationic lipid complexes inhibits murine lung metastases, Hum. Gene Ther., 10, 723, 10.1089/10430349950018481 Boucher, 1996, Tumor angiogenesis and interstitial hypertension, Cancer Res., 56, 4264 Boussif, 2001, Enhanced in vitro and in vivo cationic lipid-mediated gene delivery with a fluorinated glycerophosphoethanolamine helper lipid, J. Gene Med., 3, 109, 10.1002/jgm.166 Bragonzi, 1999, Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs, Gene Ther., 6, 1995, 10.1038/sj.gt.3301039 Bragonzi, 2000, Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs, Gene Ther., 7, 1753, 10.1038/sj.gt.3301282 Bramson, 2000, Activation of host tumoral responses by cationic lipid/DNA complexes, Cancer Gene Ther., 7, 353, 10.1038/sj.cgt.7700143 Brigham, 2000, Transfection of nasal mucosa with a normal α1-antitrypsin gene in α1-antitrypsin-deficient subjects: comparison with protein therapy, Hum. Gene Ther., 11, 1023, 10.1089/10430340050015338 Brock, 1991, Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells, Am. J. Pathol., 138, 213 Bucur, 1998, Growth inhibition of experimental glioma by human interferon-β superinduced by cationic liposomes entrapping polyinosilic:polycytidilic acid, Neurol. Med. Chir. (Tokyo), 38, 469, 10.2176/nmc.38.469 Calabretta, 1991, Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vivo study relevant to bone marrow purging, Proc. Natl. Acad. Sci. USA, 88, 2351, 10.1073/pnas.88.6.2351 Canonico, 1994, Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits, Am. J. Respir. Cell Mol. Biol., 10, 24, 10.1165/ajrcmb.10.1.8292378 Cao, 2000, Delivery and pathway in MCF7 cells of DNA vectorized by cationic liposomes derived from cholesterol, Antisense Nucl. Acid Drug Dev., 10, 369, 10.1089/oli.1.2000.10.369 Caplen, 1995, Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis, Nat. Med., 1, 39, 10.1038/nm0195-39 Chapman, 1992, Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter, Circ. Res., 71, 27, 10.1161/01.RES.71.1.27 Chen, 1999, Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice, Cancer Res., 59, 3308 Chen, 2000, Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes, Gene Ther., 7, 1698, 10.1038/sj.gt.3301294 Choi, 2001, New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity, Bioconjugate Chem., 12, 108, 10.1021/bc000081o Chon, 1991, The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes, J. Immunol., 146, 4234, 10.4049/jimmunol.146.12.4234 Clarke, 1996, Gene transfer therapy of Gaucher disease, Transfus. Sci., 17, 45, 10.1016/0955-3886(95)00057-7 Conary, 1994, Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene, J. Clin. Invest., 93, 1834, 10.1172/JCI117169 Crook, 1998, Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum, Gene Ther., 5, 137, 10.1038/sj.gt.3300554 Curtis, 1998, Restoration by intratracheal gene transfer of bicarbonate secretion in cystic fibrosis mouse gallbladder, Am. J. Physiol., 274, G1053 Das, 2001, Use of perfluorocarbon (Fluorinert) to enhance reporter gene expression following intratracheal instillation into the lungs of Balb/c mice: implications for nebulized delivery of plasmids, J. Pharm. Sci., 90, 1336, 10.1002/jps.1086 Dass, C.R., 1998. Targeted delivery of DNA for therapy of cancer. PhD thesis, Charles Sturt University, Wagga Wagga, Australia. Dass, 2002, Vehicles for oligonucleotide delivery: therapeutic applicability against tumors, J. Pharm. Pharmacol., 54, 3, 10.1211/0022357021771887 Dass, 1999, Lipoplexes and tumors, J. Pharm. Pharmacol., 51, 755, 10.1211/0022357991773113 Dass, 1999, Microsphere-mediated targeted gene therapy of solid tumors, Drug Deliv., 6, 243, 10.1080/107175499266832 Dass, C.R., DeCruz, E.E., Walker, T.L., Burton, M.A. 1997a. Limitation of lipoplexes for gene therapy of solid tumors. Australas. Pharm. Sc. Assoc. 1997 Conf. Proc., p. 39. Dass, 1997, Tumor gene-targeting using microspheres: cell culture and in vivo studies, Drug Deliv., 4, 263, 10.3109/10717549709052012 Dass, 2000, Apolipoprotein A-I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis, J. Pharm. Pharmacol., 52, 731, 10.1211/0022357001774606 Dass, 2000, Delivery of lipoplexes for genotherapy of solid tumors: role of vascular endothelial cells, J. Pharm. Pharmacol., 52, 1301, 10.1211/0022357001777450 Dass, 2002, Liposomes containing cationic dimethyl dioctadecyl ammonium bromide (DDAB): formulation, quality control and lipofection efficiency, Drug Deliv., 9, 11, 10.1080/107175402753413136 Dass, 1996, In vitro evaluation of ion-exchange microspheres as carriers of plasmid DNA, Pharm. Sci., 2, 401 Dass, 1999, A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. I. Construction and in vitro evaluation, Drug Deliv., 6, 259, 10.1080/107175499266850 Dass, 2000, A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumor model, Drug Deliv., 7, 15, 10.1080/107175400266740 Delepine, 2000, Cationic phosphonolipids as nonviral vectors: in vitro and in vivo applications, J. Pharm. Sci., 89, 629, 10.1002/(SICI)1520-6017(200005)89:5<629::AID-JPS8>3.0.CO;2-P Dow, 1999, Intravenous cytokine gene delivery by lipid–DNA complexes controls the growth of established lung metastases, Hum. Gene Ther., 10, 2961, 10.1089/10430349950016375 Dow, 1999, Lipid–DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously, J. Immunol., 163, 1552, 10.4049/jimmunol.163.3.1552 Duda, 2000, Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin 12, Cancer Res., 60, 1111 Dunphy, 1999, Reciprocal enhancement of gene transfer by combinatorial adenovirus transduction and plasmid DNA transfection in vitro and in vivo, Hum. Gene Ther., 10, 2407, 10.1089/10430349950017059 Egilmez, 1996, In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery, Gene Ther., 3, 607 Endo, 2000, TGF-α antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo, Gene Ther., 7, 1906, 10.1038/sj.gt.3301315 Escriou, 1998, Cationic lipid-mediated gene transfer: effect of serum on cellular uptake and intracellular fate of lipoployamine/DNA complexes, Biochim. Biophys. Acta, 1368, 276, 10.1016/S0005-2736(97)00194-6 Farhood, 1992, Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity, Biochim. Biophys. Acta, 1111, 239, 10.1016/0005-2736(92)90316-E Farhood, 1995, The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer, Biochim. Biophys. Acta, 1235, 289, 10.1016/0005-2736(95)80016-9 Fasbender, 1995, Optimization of cationic lipid-mediated gene transfer to airway epithelia, Am. J. Physiol., 269, L45 Felgner, 1987, Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure, Proc. Natl. Acad. Sci. USA, 84, 7413, 10.1073/pnas.84.21.7413 Felgner, 1994, Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations, J. Biol. Chem., 269, 2550, 10.1016/S0021-9258(17)41980-6 Fenart, 1999, Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain carrier, J. Pharmacol. Exp. Ther., 291, 1017 Ferdous, 1996, Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma, Biopharm. Drug Dispos., 17, 145, 10.1002/(SICI)1099-081X(199603)17:2<145::AID-BDD942>3.0.CO;2-Y Ferencick, 1990, Immunomodulatory activity of some amphiphilic compounds, Pharmazie, 45, 695 Ferrara, 1999, Role of vascular endothelial growth factor in the regulation of angiogenesis, Kidney Int., 56, 794, 10.1046/j.1523-1755.1999.00610.x Ferrari, 2001, Trends in lipoplex physical properties dependent on cationic lipid structure, vehicle and complexation procedure do not correlate with biological activity, Nucl. Acids Res., 29, 1539, 10.1093/nar/29.7.1539 Filion, 1997, Anti-inflammatory activity of cationic lipids, Br. J. Pharmacol., 122, 551, 10.1038/sj.bjp.0701396 Filion, 1997, Toxicity and immunomodulatory activity of some liposomal vectors formulated with cationic lipids toward immune effector cells, Biochim. Biophys. Acta, 1329, 345, 10.1016/S0005-2736(97)00126-0 Filion, 1998, Major limitations in the use of cationic liposomes for DNA delivery, Int. J. Pharm., 162, 159, 10.1016/S0378-5173(97)00423-7 Floch, 2000, Cation substitution in cationic phosphonolipids: a new concept to improve transfection activity and decrease cellular toxicity, J. Med. Chem., 43, 4617, 10.1021/jm000006z Floch, 2000, Systemic administration of cationic phosphonolipid/DNA complexes and the relationship between formulation and lung transfection efficiency, Biochim. Biophys. Acta, 1464, 95, 10.1016/S0005-2736(99)00250-3 Freimark, 1998, Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes, J. Immunol., 160, 4580, 10.4049/jimmunol.160.9.4580 Friend, 1996, Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes, Biochim. Biophys. Acta, 1278, 41, 10.1016/0005-2736(95)00219-7 Gaber, 1996, Thermosensitive liposomes: extravasation and release of contents in tumor microvascular netwroks, Int. J. Radiat. Oncol. Biol. Phys., 36, 1177, 10.1016/S0360-3016(96)00389-6 Ghosh, 2000, Nature of linkage between the cationic headgroup and cholesteryl skeleton controls gene transfection efficiency, FEBS Lett., 473, 341, 10.1016/S0014-5793(00)01558-1 Gill, 1997, A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis, Gene Ther., 4, 199, 10.1038/sj.gt.3300391 Griesenbach, 1998, Comparison between intratracheal and intravenous administration of liposome–DNA complexes for cystic fibrosis lung gene therapy, Gene Ther., 5, 181, 10.1038/sj.gt.3300562 Hafez, 2001, On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids, Gene Ther., 8, 1188, 10.1038/sj.gt.3301506 Harada, 2000, Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer, Cancer Gene Ther., 7, 27, 10.1038/sj.cgt.7700079 Harashima, 1995, Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling, J. Drug Target., 3, 253, 10.3109/10611869509015954 Harrison, 1995, Optimization of gene transfer using cationic lipids in cell lines and primary human CD4+ and CD34+ hematopoietic cells, Biotechniques, 19, 816 He, 1998, Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter, J. Natl. Cancer Inst., 90, 1080, 10.1093/jnci/90.14.1080 Heyes, 2002, Synthesis of novel cationic lipids: effect of structural modification on the efficiency of gene transfer, J. Med. Chem., 45, 99, 10.1021/jm010918g Hobbs, 1998, Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment, Proc. Natl. Acad. Sci. USA, 95, 4607, 10.1073/pnas.95.8.4607 Hofland, 1997, In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex, Pharm. Res., 14, 742, 10.1023/A:1012146305040 Hong, 1997, Stabilization of cationic liposome–plasmid DNA complexes by polyamines and poly(ethylene glycol)–phospholipid conjugates for efficient in vivo gene delivery, FEBS Lett., 400, 233, 10.1016/S0014-5793(96)01397-X Hortobagyi, 2001, Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a Phase I clinical trial, J. Clin. Oncol., 19, 3422, 10.1200/JCO.2001.19.14.3422 Hottiger, 1999, Liposome-mediated gene transfer into human basal cell carcinoma, Gene Ther., 6, 1929, 10.1038/sj.gt.3301036 Hui, 1997, Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA–liposome complexes, Gene Ther., 4, 783, 10.1038/sj.gt.3300455 Hwang, 2001, Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes, Gene Ther., 8, 1276, 10.1038/sj.gt.3301510 Hyde, 2000, Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis, Gene Ther., 7, 1156, 10.1038/sj.gt.3301212 Ishiwata, 2000, Characteristics and biodistribution of cationic liposomes, and their DNA complexes, J. Controlled Release, 69, 139, 10.1016/S0168-3659(00)00293-5 Jaaskelainen, 2000, A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of antisense phosphorothioate oligonucleotides, Eur. J. Pharm. Sci., 10, 187, 10.1016/S0928-0987(00)00068-3 Jahnova, 1994, Amphiphilic detergents inhibit production of IgG and IgM by human peripheral blood mononuclear cells, Immunol. Lett., 39, 71, 10.1016/0165-2478(93)90166-Y Jain, 2001, Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function, J. Contr. Rel., 74, 7, 10.1016/S0168-3659(01)00306-6 Jeschke, 1999, Attenuation of the acute-phase response in thermally injured rats by cholesterol-containing cationic liposomes used as a delivery system for gene therapy, Arch. Surg., 134, 1098, 10.1001/archsurg.134.10.1098 Juliano, 1975, The effect of particle size and charge on clearance on the clearance rates of liposomes and liposome encapsulated drugs, Biochem. Biophys. Res. Commun., 63, 651, 10.1016/S0006-291X(75)80433-5 Kariko, 1998, Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA, Biochim. Biophys. Acta, 1369, 320, 10.1016/S0005-2736(97)00238-1 Kawaura, 1998, Atomic force microscopy for studying gene transfection mediated by cationic liposomes with a cationic cholesterol derivative, FEBS Lett., 421, 69, 10.1016/S0014-5793(97)01532-9 Kong, 2000, Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size, Cancer Res., 60, 4440 Lambert, 1998, Effect of polyisobutylcyanoacrylate nanoparticles and lipofectin loaded with oligonucleotides on cell viability and PKC alpha neosynthesis in HepG2 cells, Biochimie, 80, 969, 10.1016/S0300-9084(99)80002-9 Lanuti, 2000, Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal models, Cancer Res., 60, 2955 Lappalainen, K., Jääskeläinen, I., Syrjänen, K., Urtti, A., Syrjänen, S., 1994. Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm. Res. 11, 1127–1131. Lascombe, 1996, Gene transfer into subcultured endometrial cells using lipofection, Biotechniques, 20, 88, 10.2144/96201st03 Lasic, 1996, Liposomes and lipidic particles in gene therapy, 477 Leclerc, 1992, Percutaneous arterial gene transfer in a rabbit model, J. Clin. Invest., 90, 936, 10.1172/JCI115970 Lee, 1998, Isolated lung liposome-mediated gene transfer produces organ-specific transgenic expression, Ann. Thorac. Surg., 66, 903, 10.1016/S0003-4975(98)00603-1 Lee, 1996, Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung, Hum. Gene Ther., 7, 1701, 10.1089/hum.1996.7.14-1701 Lee, 2000, Enhancement of adenoviral transduction with polycationic liposomes in vivo, Cancer Gene Ther., 7, 1329, 10.1038/sj.cgt.0236 Leibiger, 1991, Expression of exogenous DNA in rat liver cells after liposome-mediated transfection in vivo, Biochem. Biophys. Res. Commun., 174, 1223, 10.1016/0006-291X(91)91552-N Leonetti, 2001, Encapsulation of c-myc antisense oligodeoxynucleotides in lipid particles improves antitumoral efficacy in vivo in a human melanoma line, Cancer Gene Ther., 8, 459, 10.1038/sj.cgt.7700326 Lesoon-Wood, 1995, Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice, Hum. Gene Ther., 6, 395, 10.1089/hum.1995.6.4-395 Leventis, 1990, Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles, Biochim. Biophys. Acta., 1023, 124, 10.1016/0005-2736(90)90017-I Li, 1999, Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors, Am. J. Physiol., 276, L796 Lim, 1991, Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog, Circ. Res., 83, 2007, 10.1161/01.CIR.83.6.2007 Liotta, 1976, The significance of heterogeneous tumor cell clumps in the metastatic process, Cancer Res., 36, 889 Litzinger, 1996, Fate of cationic liposomes and their complex with oligonucleotide in vivo, Biochim. Biophys. Acta, 1281, 139, 10.1016/0005-2736(95)00268-5 Litzinger, 1994, Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes, Biochim. Biophys. Acta, 1190, 99, 10.1016/0005-2736(94)90038-8 Liu, 2002, Development of non-viral vectors for systemic gene delivery, J. Contr. Rel., 78, 259, 10.1016/S0168-3659(01)00494-1 Liu, 1995, Cationic liposome-mediated intravenous gene delivery, J. Biol. Chem., 270, 24 864, 10.1074/jbc.270.42.24864 Liu, 1992, Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes, Biochim. Biophys. Acta, 1104, 95, 10.1016/0005-2736(92)90136-A Liu, 1997, Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration, Gene Ther., 4, 517, 10.1038/sj.gt.3300424 Liu, 1999, Systemic gene delivery expands the repertoire of effective antiangiogenic agents, J. Biol. Chem., 274, 13 338, 10.1074/jbc.274.19.13338 Loisel, 2001, Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes, Hum. Gene Ther., 12, 685, 10.1089/104303401300057405 Losordo, 1994, Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo, Circulation, 89, 785, 10.1161/01.CIR.89.2.785 Madry, 2001, Efficacy of cationic liposome-mediated gene transfer to mesangial cells in vitro and in vivo, J. Mol. Med., 79, 184, 10.1007/s001090000186 Mahato, 1998, Biodistribution and gene expression of lipid/plasmid complexes after systemic administration, Hum. Gene Ther., 9, 2083, 10.1089/hum.1998.9.14-2083 Malone, 1996, Toxicology of non-viral gene transfer, 4.1.1 Marley, 2000, Hypertension in unilaterally nephrectomized rats induced by single-kidney transfection with angiotensinogen cDNA, Kidney Blood Press. Res., 23, 42, 10.1159/000025953 McClarrinon, 1999, In vivo studies of gene expression via transient transgenesis using lipid–DNA delivery, DNA Cell Biol., 18, 533, 10.1089/104454999315088 McLean, 1997, Organ-specific endothelial cell uptake of cationic liposome–DNA complexes in mice, Am. J. Physiol., 273, H387 Meyer, 2000, Multiple systemic expression of human interferon-β in mice can be achieved upon repeated administration of optimized pcTG90-lipoplex, Gene Ther., 7, 1606, 10.1038/sj.gt.3301289 Minchin, 2001, Polyinosinic acid and polycationic liposomes attenuate the hepatic clearance of circulating plasmid DNA, J. Pharmacol. Exp. Ther., 296, 1006 Mizuno, 1998, Effect of human interferon-β gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells, Cancer Immunol. Immunother., 47, 227, 10.1007/s002620050525 Mizuta, 2000, Inhibitory effects of an antisense oligonucleotide in an experimentally infected mouse model of influenza A virus, Biochem. Biophys. Res. Commun., 279, 158, 10.1006/bbrc.2000.3924 Mohr, 2001, Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice, Hum. Gene Ther., 12, 799, 10.1089/104303401750148748 Morse, 2000, Technology evaluation: gene therapy (IL-2), Valentis Inc., Curr. Opin. Mol. Ther., 2, 448 Mortimer, 1999, Cationic lipid-mediated transfection of cells in culture requires mitotic activity, Gene Ther., 6, 403, 10.1038/sj.gt.3300837 Mui, 2000, Membrane perturbation and the mechanism of lipid-mediated transfer of DNA into cells, Biochim. Biophys. Acta, 1467, 281, 10.1016/S0005-2736(00)00226-1 Mui, 2001, Immune stimulation by a CpG-containing oligodeoxynucleotide in enhanced when encapsulated and delivered in lipid particles, J. Pharmacol. Exp. Ther., 298, 1185 Muller, 1994, Catheter-mediated pulmonary vascular gene transfer and expression, Circ. Res., 75, 1039, 10.1161/01.RES.75.6.1039 Murray, 1995, Targeting solid tumors: challenges, disappointments, and opportunities, Adv. Drug Deliv. Rev., 17, 117, 10.1016/0169-409X(95)00044-8 Nabel, 1996, Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA–liposome complexes, Proc. Natl. Acad. Sci. USA, 93, 15 388, 10.1073/pnas.93.26.15388 Nabel, 1992, Gene transfer in vivo with DNA–liposome complexes: lack of autoimmunity and gonadal localization, Hum. Gene Ther., 3, 649, 10.1089/hum.1992.3.6-649 Nabel, 1993, Direct gene transfer with DNA–liposome complexes in melanoma: expression, biological activity, and lack of toxicity in humans, Proc. Natl. Acad. Sci. USA, 90, 11 307, 10.1073/pnas.90.23.11307 Nabel, 1990, Site-specific gene expression in vivo by direct gene transfer into the arterial wall, Science, 249, 1285, 10.1126/science.2119055 Nabel, 1992, Transduction of a foreign histocompatibility gene into the arterial wall induced vasculitis, Proc. Natl. Acad. Sci. USA, 89, 5157, 10.1073/pnas.89.11.5157 Nabel, 1993, Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo, J. Clin. Invest., 91, 1822, 10.1172/JCI116394 Nabel, 1994, Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma, Hum. Gene Ther., 5, 1089, 10.1089/hum.1994.5.9-1089 Nagayasu, 1996, Is control of distribution of liposomes between tumors and bone marrow possible?, Biochim. Biophys. Acta, 1278, 29, 10.1016/0005-2736(95)00188-3 Namoto, 1998, Heterogeneous induction of apoptosis in colon cancer cells by wild-type p53 gene transfection, Int. J. Oncol., 12, 777 Natsume, 1999, Antitumor effect and cellular immunity activation by murine interferon-β gene transfer against intracerebral glioma in mouse, Gene Ther., 6, 1626, 10.1038/sj.gt.3300990 Neckers, 1998, Non-antisense oligonucleotide approaches for experimental treatment of glioblastoma, Antisense Nucl. Acid Drug Dev., 8, 177, 10.1089/oli.1.1998.8.177 Needham, 2000, A new temperature sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model, Cancer Res., 60, 1197 Nishi, 1996, High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation, Cancer Res., 56, 1050 Nita, 1996, Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo, Arthr. Rheum., 39, 820, 10.1002/art.1780390515 Nomura, 1997, Intratumoral pharmacokinetics and in vivo gene expression of naked plasmid DNA and its cationic liposome complexes after direct gene transfer, Cancer Res., 57, 2681 Noone, 2000, Safety and biological efficacy of a lipid–CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis, Mol. Ther., 1, 105, 10.1006/mthe.1999.0009 Ochiya, 1999, Evaluation of cationic liposome suitable for gene transfer into pregnant animals, Biochem. Biophys. Res. Commun., 258, 358, 10.1006/bbrc.1999.0590 Osaka, 1996, Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach, J. Pharm. Sci., 85, 612, 10.1021/js9504494 Ozmen, 1994, Interleukin 12, interferon γ, and tumor necrosis factor α are the key cytokines of the generalized Shwartzmann reaction, J. Exp. Med., 180, 907, 10.1084/jem.180.3.907 Pampinella, 2000, Gene transfer in skeletal muscle by systemic injection of DODAC lipopolyplexes, Neurol. Sci., 21, S967, 10.1007/s100720070011 Parker, 1996, Plasmid DNA gene therapy: studies with the human interleukin-12 gene in tumor cells in vitro and in the murine B16 model in vivo, Cancer Gene Ther., 3, 175 Parker, 1995, Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates, Hum. Gene Ther., 6, 575, 10.1089/hum.1995.6.5-575 Pauli, C., Naujoks, K., Mundl, H., Lang, S., Zeidler, R., Kastenbauer, E., Wollenberg, B., 1998. Gene therapy of HNSCC with liposomal mediated h-IL-2 plasmids—phase I-study. Int. Symp. Metastases Head Neck Cancer, Kiel, Germany: abs. 15.17. Perrie, 2001, Liposome-mediated DNA vaccination: the effect of vesicle composition, Vaccine, 19, 3301, 10.1016/S0264-410X(00)00432-1 Pickering, 1994, Liposome-mediated gene transfer into human vascular smooth muscle cells, Circulation, 89, 13, 10.1161/01.CIR.89.1.13 Pleyer, 2001, Efficiency and toxicity of liposome-mediated gene transfer to corneal epithelial cells, Exp. Eye Res., 73, 1, 10.1006/exer.2001.1005 Porteous, 1997, Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis, Gene Ther., 4, 210, 10.1038/sj.gt.3300390 Qin, 1997, Promoter attenuation in gene therapy: interferon-γ and tumor necrosis factor-α inhibit transgene expression, Hum. Gene Ther., 8, 2019, 10.1089/hum.1997.8.17-2019 Rainov, 1999, Intraarterial delivery of adenovirus vectors and liposome–DNA complexes to experimental brain neoplasms, Hum. Gene Ther., 10, 311, 10.1089/10430349950019093 Ren, 2000, Structural basis of DOTMA for its high intravenous transfection activity in mouse, Gene Ther., 7, 764, 10.1038/sj.gt.3301153 Reyes, 2001, Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization, Vaccine, 19, 3778, 10.1016/S0264-410X(01)00090-1 Ruiz, 2001, A clinical inflammatory syndrome attributable to aerosolized lipid–DNA administration in cystic fibrosis, Hum. Gene Ther., 12, 751, 10.1089/104303401750148667 Ruponen, 1999, Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies, Biochim. Biophys. Acta, 1415, 331, 10.1016/S0005-2736(98)00199-0 Saijo, 1994, Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice, Oncol. Res., 6, 243 Sakurai, 2001, Interaction between DNA–cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid, Gene Ther., 8, 677, 10.1038/sj.gt.3301460 San, 1993, Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy, Hum. Gene Ther., 4, 781, 10.1089/hum.1993.4.6-781 Santiago, 1999, New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury, Nat. Med., 5, 1264, 10.1038/15215 Saravolac, 2000, Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity, J. Drug Target., 7, 423, 10.3109/10611860009102217 Schmid, 1998, Direct gene transfer into the rat pancreas using DNA–liposomes, Eur. J. Clin. Invest., 28, 220, 10.1046/j.1365-2362.1998.00269.x Schuele, 2000, The role of CpG motifs in immunostimulation and gene therapy, Adv. Drug Deliv. Rev., 44, 119, 10.1016/S0169-409X(00)00090-9 Schuele, 1997, Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung, Hum. Gene Ther., 8, 689, 10.1089/hum.1997.8.6-689 Semple, 2000, Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures, Biochim. Biophys. Acta, 1508, 1 Senior, 1991, Interaction of positively-charged liposomes with blood: implications for their application in vivo, Biochim. Biophys. Acta, 1070, 173, 10.1016/0005-2736(91)90160-A Seung, 1995, Genetic radiotherapy overcomes tumor resistance to cytotoxic agents, Cancer Res., 55, 5561 Smith, 1998, Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model, J. Natl. Cancer Inst., 90, 1146, 10.1093/jnci/90.15.1146 Smith, 1998, Characterization and in vivo testing of a heterogeneous cationic lipid–DNA formulation, Pharm. Res., 15, 1356, 10.1023/A:1011937218418 Son, 1994, Exposure of human ovarian carcinoma to cisplatin transiently sensitizes the tumor cells for liposome-mediated gene transfer, Proc. Natl. Acad. Sci. USA, 91, 12 669, 10.1073/pnas.91.26.12669 Son, 1996, Factors influencing the drug sensitization of human tumor cells for in situ lipofection, Gene Ther., 3, 630 Son, 2000, Efficient in vivo gene delivery by the negatively charged complexes of cationic liposomes and plasmid DNA, Biochim. Biophys. Acta, 1468, 6, 10.1016/S0005-2736(00)00311-4 Song, 1998, Free liposomes enhance the transfection activity of DNA/lipid complexes in vivo by intravenous administration, Biochim. Biophys. Acta, 1372, 141, 10.1016/S0005-2736(98)00054-6 Song, 1998, Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmids DNA, Gene Ther., 5, 1531, 10.1038/sj.gt.3300770 Sorscher, 1994, Gene therapy for cystic fibrosis using cationic liposome mediated gene transfer: a phase I trial of safety and efficacy in the nasal airway, Hum. Gene Ther., 5, 1259, 10.1089/hum.1994.5.10-1259 Sparwasser, 1997, Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-α-mediated shock, Eur. J. Immunol., 27, 1671, 10.1002/eji.1830270712 Staggs, 1996, Importance of liposome complexing volume in transfection optimization, Biotechniques, 21, 792, 10.2144/96215bm08 Stephan, 1996, A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo, Hum. Gene Ther., 7, 1803, 10.1089/hum.1996.7.15-1803 Stewart, 1992, Gene transfer in vivo with DNA–liposome complexes: safety and acute toxicity in mice, Hum. Gene Ther., 3, 267, 10.1089/hum.1992.3.3-267 Stopeck, 2001, Phase II study of direct intralesional gene transfer of Allovectin-7, an HLA-B7/β2-microglobulin DNA–liposome complex, in patients with metastatic melanoma, Clin. Cancer Res., 7, 2285 Strieter, 1995, The role of CXC chemokines as regulators of angiogenesis, Shock, 4, 155, 10.1097/00024382-199509000-00001 Stuart, 2000, A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1, Cancer Gene Ther., 7, 466, 10.1038/sj.cgt.7700145 Szala, 1996, The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors, Gene Ther., 3, 1026 Tagawa, 1996, Gene expression and active virus replication in the liver after injection of duck hepatitis B virus DNA into the peripheral vein of ducklings, J. Hepatol., 24, 328, 10.1016/S0168-8278(96)80013-4 Takakuwa, 1997, Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA–liposome complexes: growth inhibition of tumors and lack of localization in normal tissues, Jpn. J. Cancer Res., 88, 166, 10.1111/j.1349-7006.1997.tb00362.x Takeshita, 1994, Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation, J. Clin. Invest., 93, 652, 10.1172/JCI117017 Tan, 1999, The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo, Hum. Gene Ther., 10, 2153, 10.1089/10430349950017149 Tang, 1999, Use of dithiodiglycolic acid as a tether for cationic lipids decreases the cytotoxicity and increases transgene expression of plasmid DNA in vitro, Bioconjug. Chem., 10, 791, 10.1021/bc990016i Tang, 1999, Synthesis of a single-tailed cationic lipid and investigation of its transfection, J. Contr. Rel., 62, 345, 10.1016/S0168-3659(99)00158-3 Taniguchi, 1988, Assessment of ocular irritability of liposome preparations, J. Pharmacobiodynamic, 11, 607, 10.1248/bpb1978.11.607 Thierry, 1995, Systemic gene therapy: biodistribution and long-term expression of a transgene in mice, Proc. Natl. Acad. Sci. USA, 92, 9742, 10.1073/pnas.92.21.9742 Thurston, 1998, Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice, J. Clin. Invest., 101, 1401, 10.1172/JCI965 Tsan, 1995, Lung-specific direct in vivo gene transfer with recombinant plasmid DNA, Am. J. Physiol., 268, L1052 Tu, 2000, Non-replicating Epstein–Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo, J. Biol. Chem., 275, 30408, 10.1074/jbc.M004782200 Turek, 2000, Formulations which increase the size of lipoplexes prevent serum-associated inhibition of transfection, J. Gene Med., 2, 32, 10.1002/(SICI)1521-2254(200001/02)2:1<32::AID-JGM78>3.0.CO;2-U Uyechi, 2001, Mechanism of lipoplex gene delivery in mouse lung: binding and internalization of fluorescent lipid and DNA components, Gene Ther., 8, 828, 10.1038/sj.gt.3301461 van der Woude, 1997, Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery, Proc. Natl. Acad. Sci. USA, 94, 1160, 10.1073/pnas.94.4.1160 Wasan, 1999, A multi-step lipid mixing assay to model structural changes in cationic lipoplexes used for in vitro transfection, Biochim. Biophys. Acta, 1461, 27, 10.1016/S0005-2736(99)00144-3 Watanabe, 2000, Immunoliposome-mediated gene transfer into cultured myotubes, Tohoku J. Exp. Med., 192, 173, 10.1620/tjem.192.173 Wheeler, 1996, A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung, Proc. Natl. Acad. Sci. USA, 93, 11 454, 10.1073/pnas.93.21.11454 Whitmore, 1999, LPD lipoployplex initiates a potent cytokine response and inhibits tumor growth, Gene Ther., 6, 1867, 10.1038/sj.gt.3301026 Wong, 1996, Cationic lipid binding to DNA: characterization of complex formation, Biochemistry, 35, 5756, 10.1021/bi952847r Wright, 1998, β-Galactosidase staining following intracoronary infusion of cationic liposomes in the in vivo rabbit heart is produced by microinfarction rather than effective gene transfer: a cautionary tale, Gene Ther., 5, 301, 10.1038/sj.gt.3300590 Xing, 1998, Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy, Adv. Drug. Deliv. Rev., 30, 219, 10.1016/S0169-409X(97)00118-X Xu, 1998, In vivo gene therapy with a cationic polymer markedly enhances the antitumor activity of antiangiogenic genes, Mol. Genet. Metab., 64, 193, 10.1006/mgme.1998.2705 Xu, 1997, Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity, Hum. Gene Ther., 8, 177, 10.1089/hum.1997.8.2-177 Xu, 1999, Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts, Hum. Gene Ther., 10, 2941, 10.1089/10430349950016357 Yagi, 1994, Interferon-β endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain, Biochem. Mol. Biol. Int., 32, 167 Yamazaki, 2000, Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethyleneimine, Gene Ther., 7, 1148, 10.1038/sj.gt.3301217 Yanase, 1998, Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study, Jpn. J. Cancer Res., 89, 463, 10.1111/j.1349-7006.1998.tb00586.x Yang, 1998, Time-dependent maturation of cationic liposome–DNA complex for serum resistance, Gene Ther., 5, 380, 10.1038/sj.gt.3300596 Yerulshami, 2000, Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes, Cancer Gene Ther., 7, 91, 10.1038/sj.cgt.7700115 Yew, 1999, Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes, Hum. Gene Ther., 10, 223, 10.1089/10430349950019011 Yew, 2000, Reduced inflammatory response to plasmid vectors by elimination and inhibition of immunostimulatory CpG motifs, Mol. Ther., 1, 255, 10.1006/mthe.2000.0036 Yokoyama, 1996, DNA immunization: effects of vehicle and route of administration on the induction of protective antiviral immunity, FEMS Immunol. Med. Microbiol., 14, 221, 10.1111/j.1574-695X.1996.tb00290.x Zabner, 1995, Cellular and molecular barriers to gene transfer by a cationic lipid, J. Biol. Chem., 270, 18 997, 10.1074/jbc.270.32.18997 Zerrouqi, 1996, Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir, Cancer Gene Ther., 3, 385 Zhao, 1996, Oligonucleotide uptake in human hematopoietic cells is increased in leukemia and is related to cellular activation, Blood, 88, 1788, 10.1182/blood.V88.5.1788.1788 Zhu, 1993, Systemic gene expression after intravenous DNA delivery into adult mice, Science, 261, 209, 10.1126/science.7687073 Zhu, 1996, A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy, Gene Ther., 3, 472 Zou, 1995, Effect of vesicle size and lipid composition on the in vivo tumor selectively and toxicity of the non-cross-resistant anthracycline annamycin incorporated in liposomes, Int. J. Cancer, 61, 666, 10.1002/ijc.2910610513 Zuidam, 1998, Electrostatic and structural properties of complexes involving plasmid DNA and cationic lipids commonly used for gene delivery, Biochim. Biophys. Acta, 1368, 115, 10.1016/S0005-2736(97)00187-9